LEADER 02042oas  22008293  450 
001 9910284457503321
005 20251008213014.0
011   $a2045-0931
035   $a(DE-599)ZDB2756098-3
035   $a(OCoLC)889934736
035   $a(CONSER)  2015243376
035   $a(CKB)2670000000554045
035   $a(EXLCZ)992670000000554045
100   $a20100813a20149999  uy         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cn$2rdamedia
183   $acr$2rdacarrier
200 00$aHepatic oncology
210  1$aLondon :$cFuture Medicine,$d2014-
210 31$a[Milton Park, Oxfordshire] :$cinforma UK limited, trading as taylor & Francis group
215   $a1 online resource $cillustrations (some colour)
300   $aRefereed/Peer-reviewed
300   $aTitle from table of contents page (Future Medicine, viewed January 23, 2014).
311 08$a2045-0923 
517 3 $aHepat Oncol
531 0 $aHepat. oncol.
606   $aLiver$xCancer$vPeriodicals
606   $aLiver Neoplasms
606   $aFoie$xCancer$vPe?riodiques
606   $aLiver$xCancer$2fast
608   $aPeriodical
608   $aPeriodicals$2fast
615  0$aLiver$xCancer
615 12$aLiver Neoplasms
615  6$aFoie$xCancer
615  7$aLiver$xCancer
676   $a616.99436005
801  0$bAU@
801  1$bAU@
801  2$bOCLCO
801  2$bOCLCF
801  2$bCUI
801  2$bNLE
801  2$bCOO
801  2$bOCLCO
801  2$bUKMGB
801  2$bWYU
801  2$bOCLCO
801  2$bOCLCA
801  2$bVT2
801  2$bUSU
801  2$bOCLCQ
801  2$bSFB
801  2$bCNMTR
801  2$bHS0
801  2$bUWK
801  2$bLUN
801  2$bSXB
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCQ
801  2$bOCLCO
801  2$bNLM
801  2$bUEJ
801  2$bDLC
801  2$bU3W
906   $aJOURNAL
912   $a9910284457503321
996   $aHepatic oncology$92276232
997   $aUNINA